Budapest, Hungary

Péter Seres


Average Co-Inventor Count = 21.0

ph-index = 1


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Péter Seres

Introduction: Péter Seres, an accomplished inventor based in Budapest, Hungary, has made significant strides in the field of pharmaceutical chemistry. Known for his innovative approach, Seres has secured a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents: The notable patent held by Péter Seres is for "8-substituted-9H-1,3-dioxolo[4,5-h][2,3]benzodiazepine derivatives as AMPA/kainate receptor inhibitors." This invention presents a novel compound with unique properties aimed at inhibiting the AMPA/kainate receptors, which may have beneficial effects in treating various diseases. The patent provides detailed insight into the compound, including its formula, preparation process, and pharmaceutical applications, highlighting its potential in advancing therapeutic treatments.

Career Highlights: Péter Seres works at Egis Gyogyszergyar Rt., a well-respected pharmaceutical company. His research and development efforts within the company have contributed to the production of valuable medical compounds, underscoring his impact in the pharmaceutical sector.

Collaborations: Throughout his career, Seres has collaborated with esteemed colleagues such as László Balázs and József Barkóczy. These collaborations have allowed for the sharing of ideas and methodologies, ultimately enhancing the innovation process and driving successful outcomes in their research initiatives.

Conclusion: Péter Seres remains a prominent figure in the field of pharmaceutical innovation. His patent and collaborative efforts exemplify the kind of dedication that propels advancements in medicine. As he continues to develop new compounds and therapies, Seres is undoubtedly making a lasting impact on the healthcare landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…